70 results on '"Garcovich, M"'
Search Results
2. T.05.4: RENAL LITHOGENIC RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES CORRELATES WITH MICROBIOTA COMPOSITION, URINARY PROFILE AND DIETARY INTAKE
3. P363 Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn’s disease treated with ustekinumab
4. P442 Renal lithogenic risk in patients with Inflammatory Bowel Diseases correlates with microbiota composition, urinary profile and dietary intake
5. P256 Urinary lithogenic profile and gut and urinary microbiota in patients with inflammatory bowel diseases
6. Hepatocellular carcinoma with portal vein tumor thrombus: a single-center retrospective analysis
7. P256 Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients
8. Short-term evaluation of hepatocellular carcinoma after locoregional treatment: Usefulness of contrast-enhanced ultrasonography
9. Assessing Baveno VI criteria with a new point-shear wave elastography technique: The BAVElastPQ study
10. A CHALLENGING CASE OF LATE RECURRENT MELANOMA MIMICKING INTESTINAL POLYPOID SYNDROME
11. P.09.10 CIRRHOTIC PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY PRESENT INCREASED CEREBRAL VASCULAR RESISTANCE, WHICH REMAINS UNCHANGED AFTER MEDICAL TREATMENT
12. P.09.30 NEW DIRECT-ACTING ANTIVIRAL (DAA) THERAPY IMPACTS LIVER STIFFNESS MEASUREMENTS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION
13. Accuracy of a Point Shear Wave Elastography Technique (ElastPQ) in the Non-Invasive Assessment of Liver Fibrosis in a Large Cohort of Liver Patients
14. Dynamic Contrast Enhanced Ultrasound Perfusion Imaging and Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: A Feasibility Study
15. P0526 : Accuracy of point shear wave elastography technique (elastpq) in the non-invasive assessment of liver fibrosis in various liver diseases
16. P1023 OUR PRELIMINARY EXPERIENCE WITH ElastPQ SHEAR WAVE ELASTOGRAPHY TECHNIQUE AND DOPPLER INDICES IN THE NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS
17. P.16.9 SHORT TREATMENT WITH RIFAXIMIN IMPROVES BLOOD CEREBRAL FLOW AT TRANSCRANIAL DOPPLER AND PSYCHOMETRIC TESTS IN CIRRHOTIC PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY
18. P.16.15 FEASIBILITY AND ACCURACY OF ELASTPQ® SHEAR WAVE ELASTOGRAPHY TECHNIQUE AND DOPPLER INDICES IN THE NON-INVASIVE ASSESSEMENT OF LIVER FIBROSIS: A PRELIMINARY EXPERIENCE
19. 457 THE QUALITY OF LIVER SPECIMEN USING TWO DIFFERENT LARGE NEEDLE BIOPSY DEVICES: A PROSPECTIVE RANDOMIZED-CONTROLLED STUDY
20. 579 ENDOTHELIAL DYSFUNCTION IN CIRRHOSIS AND ITS RELATIONSHIP WITH PORTAL HYPERTENSION AND LIVER FAILURE
21. P.11.13 EPIDEMIOLOGY OF PORTAL AND DEEP VEIN THROMBOSIS IN HOSPITALIZED CIRRHOTIC PATIENTS: A SINGLE CENTER EXPERIENCE
22. P.11.20 CLINICAL OUTCOME OF PARTIAL PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS: TO OBSERVE OR TO TREAT?
23. P.18.15 CONTRAST-ENHANCED ULTRASOUND EVALUATION OF TUMOR RESPONSE TO ANTI ANGIOGENETIC TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARINOMA
24. P.11.18 GUT MICROBIOTA ALTERATION: THE LINK BETWEEN “LEAKY GUT” AND SPONTANEOUS BACTERIAL PERITONITIS IN LIVER CIRRHOTIC PATIENTS?
25. P.11.15 IMPACT OF PORTAL VEIN THROMBOSIS ON HEPATOCELLULAR CARCINOMA TREATMENT OUTCOME. THE HEPATOCAT GROUP EXPERIENCE
26. P.13.6 TREATMENT OF PORTAL VEIN TUMOR THROMBOSIS (PVTT) CAN IMPACT SURVIVAL OF PATIENTS WITH ADVANCED HCC?
27. F-34 Epidemiology of venous thrombotic events and pulmonary embolism among hospitalized cirrhotic patients: a single center experience
28. F-29 Endothelial dysfunction in cirrhosis and its relationship with portal hypertension and liver failure
29. O6 RELATIONSHIP BETWEEN SMALL INTESTINAL BACTERIAL OVERGROWTH AND INTESTINAL PERMEABILITY IN CIRRHOSIS
30. 652 DEVELOPMENT OF A FORMULA TO ESTIMATE GLOMERULAR FILTRATION RATE (GFR) IN PATIENTS WITH CIRRHOSIS
31. 1042 SHORT-TERM EVALUATION OF HEPATOCELLULAR CARCINOMA AFTER SINGLE-STEP COMBINED TREATMENT: USEFULNESS OF CONTRAST-ENHANCED ULTRASONOGRAPHY
32. 151 REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
33. P.03.17 SHORT-TERM EVALUATION OF HEPATOCELLULAR CARCINOMA AFTER SINGLE-STEP COMBINED TREATMENT: USEFULNESS OF CONTRAST-ENHANCED ULTRASONOGRAPHY
34. P.08.13 REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
35. P.07.11 REAL-TIME EVALUATION OF ALTERED GASTRIC MOTILITY BY ULTRASONOGRAPHY IN PATIENTS WITH PARKINSON'S DISEASE
36. P.04.12 NON INVASIVE EVALUATION OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS: THE ROLE OF CONTRAST ENHANCED ULTRASOUND PERFUSION IMAGING AND DOPPLER ULTRASONOGRAPHY
37. P.08.15 SYSTEMIC ENDOTHELIAL DYSFUNCTION AS A PREDICTOR OF HYPERTENSION DEVELOPMENT IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) UNDERGOING THERAPY WITH SORAFENIB
38. P.08.8 LACK OF RESPONSE AND TUMOR RECURRENCE AFTER MULTIMODAL REPEATED TREATMENT
39. P.04.16 TACROLIMUS ADMINISTRATION AND LIVER DISEASE ETIOLOGY INFLUENCE THE DEVELOPMENT OF FATTY CHANGES OF THE LIVER GRAFT AFTER LIVER TRANSPLANTATION
40. P.04.17 THE ROLE OF CONTRAST ENHANCED ULTRASOUND PERFUSION IMAGING AND DOPPLER INDICES IN THE NON-INVASIVE ASSESSEMENT OF LIVER FIBROSIS: A PRELIMINARY EXPERIENCE
41. F-23 Lack of response and tumor recurrence after multimodal repeated treatment for hepatocellular carcinoma similarly affect HCC patients survival. A HEPATOCAT group experience
42. F-24 Short treatment with sorafenib is associated to tumor progression in patients with hepatocellular carcinoma
43. Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma
44. 633 TUMOUR SIZE OF HCC AND ITS RELATIONSHIP TO OUTCOME AFTER LIVER TRANSPLANTATION
45. 158 RELIABILITY OF SERUM CREATININE IN ASSESSING RENAL FUNCTION IS DIMINISHED IN PATIENTS WITH CIRRHOSIS AS COMPARED WITH PATIENTS WITH ORGANIC RENAL DISEASE
46. 631 OUTCOME OF LIVER TRANSPLANTATION (LT) FOR HEPATOCELLULAR CARCINOMA (HCC) ACCORDING TO DIFFERENT TRANSPLANT CRITERIA: A META-ANALYSIS
47. P.1.161: HCC PERSONALIZED TREATMENT IN THE MULTIMODAL MANAGEMENT ERA: HEPATOCAT GROUP EXPERIENCE
48. P.1.265: THE QUALITY AND ADEQUACY OF THE SPECIMEN OBTAINED BY PERCUTANEOUS LIVER BIOPSY IN LIVER TRANSPLANT RECIPIENTS: A SINGLE-CENTRE RETROSPECTIVE ANALYSIS
49. 577 SYSTEMATIC ERROR IN MELD CALCULATION BY USING SERUM CREATININE AND CREATININE-BASED EQUATIONS IN PATIENTS WITH CIRRHOSIS
50. 632 DOES THE NUMBER OF HCC NODULES IN CIRRHOSIS IMPACT ON OUTCOME AFTER LIVER TRANSPLANTATION?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.